Drug interactions
Erdafitinib + Sevelamer
Severity: Moderate
Erdafitinib and Sevelamer: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Erdafitinib raises serum phosphate as an expected effect of FGFR inhibition, and this level guides dose escalation during the first weeks of treatment. A phosphate binder such as sevelamer can mask this rise and lead to inappropriate dosing decisions.
What this interaction means in plain words
Erdafitinib and Sevelamer can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Erdafitinib belongs to Oncology; Sevelamer belongs to Miscellaneous.
Why it happens
Pharmacodynamic confounding: sevelamer binds dietary phosphate and lowers serum phosphate, obscuring the phosphate response used to titrate erdafitinib.
What to do
Avoid phosphate binders during the first 21 days of erdafitinib so the phosphate-guided dose titration is reliable. Afterward, use binders only if hyperphosphatemia needs management according to labeling.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Erdafitinib and Sevelamer, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Sevelamer
- Carbamazepine + Sevelamer Moderate
- Ciprofloxacin + Sevelamer Moderate
- Dichlorphenamide + Sevelamer Moderate
- Gabapentin + Sevelamer Moderate
- Mycophenolic acid + Sevelamer Moderate
- Roxadustat + Sevelamer Moderate
Other interactions of Erdafitinib
Frequently asked questions
Can I take Erdafitinib with Sevelamer?
MediHelp rates the interaction as moderate. Erdafitinib and Sevelamer can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erdafitinib raises serum phosphate as an expected effect of FGFR inhibition, and this level guides dose escalation during the first weeks of treatment. A phosphate binder such as sevelamer can mask this rise and lead to inappropriate dosing decisions.
How serious is the interaction between Erdafitinib and Sevelamer?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid phosphate binders during the first 21 days of erdafitinib so the phosphate-guided dose titration is reliable. Afterward, use binders only if hyperphosphatemia needs management according to labeling.
What other medicines interact with Sevelamer?
MediHelp also lists interactions of Sevelamer with, for example, Carbamazepine, Ciprofloxacin, Dichlorphenamide. The full list is on the Sevelamer page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
